Wolverine Trading’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,917
| Closed | -$448K | – | 2947 |
|
2021
Q1 | $448K | Sell |
2,917
-4,721
| -62% | -$725K | ﹤0.01% | 1024 |
|
2020
Q4 | $1.19M | Buy |
7,638
+3,024
| +66% | +$472K | ﹤0.01% | 462 |
|
2020
Q3 | $519K | Buy |
+4,614
| New | +$519K | ﹤0.01% | 632 |
|
2020
Q2 | – | Sell |
-11,151
| Closed | -$973K | – | 2292 |
|
2020
Q1 | $973K | Sell |
11,151
-6,880
| -38% | -$600K | ﹤0.01% | 406 |
|
2019
Q4 | $1.94M | Buy |
18,031
+2,954
| +20% | +$317K | ﹤0.01% | 466 |
|
2019
Q3 | $1.47M | Buy |
+15,077
| New | +$1.47M | ﹤0.01% | 300 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 2228 |
|
2019
Q1 | – | Sell |
-2,711
| Closed | -$264K | – | 2304 |
|
2018
Q4 | $264K | Buy |
+2,711
| New | +$264K | ﹤0.01% | 904 |
|
2018
Q3 | – | Sell |
-24,076
| Closed | -$2.68M | – | 2522 |
|
2018
Q2 | $2.68M | Hold |
24,076
| – | – | 0.01% | 200 |
|
2018
Q1 | $2.68M | Buy |
+24,076
| New | +$2.68M | 0.01% | 200 |
|
2017
Q4 | – | Sell |
-2,413
| Closed | -$339K | – | 2315 |
|
2017
Q3 | $339K | Sell |
2,413
-9,951
| -80% | -$1.4M | ﹤0.01% | 781 |
|
2017
Q2 | $1.51M | Buy |
12,364
+6,529
| +112% | +$799K | 0.01% | 241 |
|
2017
Q1 | $712K | Buy |
+5,835
| New | +$712K | ﹤0.01% | 449 |
|
2016
Q4 | – | Sell |
-6,887
| Closed | -$827K | – | 2290 |
|
2016
Q3 | $827K | Buy |
+6,887
| New | +$827K | ﹤0.01% | 358 |
|